Showing 1 - 10 of 5,372
We analyze the medical decision-making process, first from the perspective of a patient and then from the perspective of a health care provider. Using a decision-tree, we describe the different actions a mother can take to treat her daughter, who she suspects has otitis media — an ear...
Persistent link: https://www.econbiz.de/10012915112
Direct-to-consumer advertising of pharmaceuticals has led to questions of whether consumers benefit from the additional … physicians. More surprising, we find that increased advertising is connected with a decrease in the rate of Cox-2 prescriptions …
Persistent link: https://www.econbiz.de/10014058701
This paper investigates whether aggregate consumer learning together with consumer heterogeneity in price sensitivity could explain why (i) there is a slow diffusion of generic drugs into the market, and (ii) brand-name originators keep increasing their prices over time even after the number of...
Persistent link: https://www.econbiz.de/10014047796
Who gains from more information on the quality of pharmaceutical drugs? Are there incentives for voluntary post-approval clinical trials among pharmaceutical companies? Contrary to popular belief, this paper shows that it is not in the consumer interest that clinical evidence establishing the...
Persistent link: https://www.econbiz.de/10003373751
Numerous experiments have demonstrated the possibility of attitude polarization. For instance, Lord, Ross & Lepper (1979) partitioned subjects into two groups, according to whether or not they believed the death penalty had a deterrent effect, and presented them with a set of studies on the...
Persistent link: https://www.econbiz.de/10013043659
Theoretical papers show that optimal prevention decisions in the sense of selfprotection (i.e., primary prevention) depend not only on the level of (second-order) risk aversion but also on higher-order risk preferences such as prudence (third-order risk aversion). We study empirically whether...
Persistent link: https://www.econbiz.de/10012270623
There have been more than 500,000 opioid overdose deaths since 2000. To analyze the opioid epidemic, a model is constructed where individuals choose whether to use opioids recreationally, knowing the probabilities of addiction and dying. These odds are functions of recreational opioid usage....
Persistent link: https://www.econbiz.de/10013382024
Persistent link: https://www.econbiz.de/10011702749
approval. By contrast, patent prolongation does not affect physicians' prescription decisions and increases the likelihood of …
Persistent link: https://www.econbiz.de/10003847110
Persistent link: https://www.econbiz.de/10003977748